Walairat Laosinchai-Wolf

Author

Asuragen (United States)

Also Known As

W Laosinchai-Wolf, W. Laosinchai-Wolf, WALAIRAT LAOSINCHAI-WOLF, Walairat Laosinchai-Wolf

Publications

426

Citations

H-Index

Concepts

All Affiliations

Asuragen (United States)Woodward (United States)Hospital of the University of Pennsylvania

About

Walairat Laosinchai-Wolf is an author at Asuragen (United States) specializing in genetics, pathology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	66
2	Pathology	2	2	66
3	Genetics	2	2	66
4	Public Health	1	1	16
5	Genetic Epidemiology	1	1	16

Walairat Laosinchai-Wolf

Publications

409

Citations

H-Index

Page 1

	Year	Citations
An optimized isolation and labeling platform for accurate microRNA expression profiling Jaclyn Shingara, Kerri Keiger, Jeffrey Shelton, RNA	2005	260
Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens Thomas J. Giordano, Sylvie Beaudenon‐Huibregtse, Rupali Shinde, Human Pathology Oncogenic Gene MutationsGeneticsPostsurgical SpecimensThyroid DiseasePathology	2014	50
Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens Walairat Laosinchai-Wolf, Fei Ye, Vu Tran, Journal of Clinical Pathology	2010	23
Microsphere Bead Arrays and Sequence Validation of 5/7/9T Genotypes for Multiplex Screening of Cystic Fibrosis Polymorphisms Andrew G. Hadd, Walairat Laosinchai-Wolf, Chris R. Novak, Journal of Molecular Diagnostics Genetic AnalysisMultiplex ScreeningMolecular Diagnostic TechniquesMendelian DisorderMedicine	2004	16
Establishment of a standardized multiplex assay with the analytical performance required for quantitative measurement of BCR–ABL1 on the international reporting scale J Thomas Brown, Walairat Laosinchai-Wolf, John Hedges, Blood Cancer Journal	2011	15
Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P) Justin T. Brown, Cora Lahey, Walairat Laosinchai-Wolf, BMC Medical Genetics	2006	15
Risk-based classification of leukemia by cytogenetic and multiplex molecular methods: results from a multicenter validation study Christopher D. Gocke, James R. Mason, L Brusca, Blood Cancer Journal	2012	10
A Multiplex Technology Platform for the Rapid Analysis of Clinically Actionable Genetic Alterations and Validation for BRAF p.V600E Detection in 1549 Cytologic and Histologic Specimens David L. Smith, Aude Lamy, Sylvie Beaudenon‐Huibregtse, Archives of Pathology & Laboratory Medicine	2013	10
Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA Justin T. Brown, Ion Beldorth, Walairat Laosinchai-Wolf, Journal of Molecular Diagnostics	2019	10

Page 1